US 8722722
Raltegravir salts and crystalline forms thereof
granted A61PA61P31/00A61P31/18
Quick answer
US patent 8722722 (Raltegravir salts and crystalline forms thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/00, A61P31/18